{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T06:40:08Z","timestamp":1760856008818,"version":"build-2065373602"},"reference-count":35,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jcehepatology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical and Experimental Hepatology"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.jceh.2019.04.002","type":"journal-article","created":{"date-parts":[[2019,4,17]],"date-time":"2019-04-17T23:30:50Z","timestamp":1555543850000},"page":"150-154","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Entecavir is Safe and Effective in Long Term for the Treatment of Hepatitis B in Immunocompromised Children"],"prefix":"10.1016","volume":"10","author":[{"given":"Manzoor A.","family":"Wani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaswinder S.","family":"Sodhi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Showkat A.","family":"Zargar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ghulam N.","family":"Yatoo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Altaf","family":"Shah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheikh A.","family":"Aziz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sajad","family":"Geelani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inaamul","family":"Haq","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ghulam M.","family":"Gulzar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mushtaq","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inaamul","family":"Haq","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jceh.2019.04.002_bib1","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1016\/S0140-6736(15)61412-X","article-title":"Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013","volume":"386","author":"Schweitzer","year":"2015","journal-title":"Lancet"},{"year":"2002","series-title":"Prevention of hepatitis B in India, An Overview","key":"10.1016\/j.jceh.2019.04.002_bib2"},{"key":"10.1016\/j.jceh.2019.04.002_bib3","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1093\/infdis\/151.4.599","article-title":"Acute hepatitis B virus infection: relation of age to the clinical expression of disease and subsequent development of the carrier state","volume":"151","author":"McMahon","year":"1985","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.jceh.2019.04.002_bib4","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/j.jhep.2013.05.016","article-title":"Management of chronic hepatitis B in childhood: ESPGHAN clinical practice guidelines: consensus of an expert panel on behalf of the European Society of Pediatric Gastroenterology, Hepatology and Nutrition","volume":"59","author":"Sokal","year":"2013","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2019.04.002_bib5","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.jpeds.2003.11.022","article-title":"The development of hepatocellular carcinoma among prospectively followed children with chronic hepatitis B virus infection","volume":"144","author":"Wen","year":"2004","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.jceh.2019.04.002_bib6","doi-asserted-by":"crossref","first-page":"F456","DOI":"10.1136\/adc.2002.009837","article-title":"Natural history of hepatitis B in perinatally infected carriers","volume":"89","author":"Boxall","year":"2004","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"10.1016\/j.jceh.2019.04.002_bib7","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1097\/01.mpg.0000243438.47334.07","article-title":"Natural history of chronic hepatitis B virus infection in children of different ethnic origins: a cohort study with up to 12 years' follow-up in northern Greece","volume":"44","author":"Zacharakis","year":"2007","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.jceh.2019.04.002_bib8","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/j.1600-0609.2004.00376.x","article-title":"Prevalence of hepatitis B and C virus infection in hematological malignancies and liver injury following chemotherapy","volume":"74","author":"Takai","year":"2005","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.jceh.2019.04.002_bib9","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/1096-9071(200011)62:3<299::AID-JMV1>3.0.CO;2-0","article-title":"Frequency of hepatitis B virus reactivation in cancer patients undergoing cytotoxic chemotherapy: a prospective study of 626 patients with identification of risk factors","volume":"62","author":"Yeo","year":"2000","journal-title":"J\u00a0Med Virol"},{"key":"10.1016\/j.jceh.2019.04.002_bib10","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1053\/j.gastro.2006.04.015","article-title":"Kinetics and risk of de novo hepatitis Infection in HBsAg negative patients undergoing chemotherapy","volume":"131","author":"Hui","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jceh.2019.04.002_bib11","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/sj.bjc.6690652","article-title":"Prevalence of hepatitis B virus marker positivity and evolution of hepatitis B virus profile, during chemotherapy, in patients with solid tumours","volume":"81","author":"Alexopoulos","year":"1999","journal-title":"Br J Canc"},{"key":"10.1016\/j.jceh.2019.04.002_bib12","first-page":"458","article-title":"Screening for occult and overt hepatitis B virus infection in patients of cancer before receiving chemotherapy: looking beyond HBsAg testing","volume":"3","author":"Sodhi","year":"2015","journal-title":"Int J Adv Res"},{"key":"10.1016\/j.jceh.2019.04.002_bib13","doi-asserted-by":"crossref","first-page":"923","DOI":"10.3748\/wjg.v19.i6.923","article-title":"Testing for hepatitis B infection in prospective chemotherapy patients: a retrospective study","volume":"19","author":"Wang","year":"2013","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jceh.2019.04.002_bib14","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/mpo.10230","article-title":"Transfusion associated hepatitis in children with hematological malignancy in Northern India","volume":"41","author":"Arora","year":"2003","journal-title":"Med Pediatr Oncol"},{"key":"10.1016\/j.jceh.2019.04.002_bib15","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1111\/j.1365-2141.2006.06465.x","article-title":"Screening, prevention and treatment of viral hepatitis B reactivation in patients with hematological malignancies","volume":"136","author":"Lalazar","year":"2007","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jceh.2019.04.002_bib16","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/hep.28278","article-title":"Antiviral therapy in management of chronic hepatitis B viral infection in children: a systematic review and meta-analysis","volume":"63","author":"Jonas","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2019.04.002_bib17","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1056\/NEJMoa012452","article-title":"Clinical trial of lamivudine in children with chronic hepatitis B","volume":"346","author":"Jonas","year":"2002","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jceh.2019.04.002_bib18","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/hep.21020","article-title":"Long-term lamivudine therapy for children with HBeAg-positive chronic hepatitis B","volume":"43","author":"Sokal","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2019.04.002_bib19","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1002\/hep.25818","article-title":"Randomized, placebo-controlled trial of tenofovir disoproxil fumarate in adolescents with chronic hepatitis B","volume":"56","author":"Murray","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2019.04.002_bib20","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1111\/j.1365-2036.2012.05093.x","article-title":"Renal tubular dysfunction during long-term adefovir or tenofovir therapy in chronic hepatitis B","volume":"35","author":"Gara","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jceh.2019.04.002_bib21","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.jpeds.2007.12.020","article-title":"Decreased bone mineral density with off-label use of tenofovir in children and adolescents infected with human immunodeficiency virus","volume":"152","author":"Purdy","year":"2008","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.jceh.2019.04.002_bib22","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/hep.28015","article-title":"Randomized controlled trial of entecavir vs placebo in children with Hepatitis B envelope Ag-positive chronic Hepatitis B","volume":"63","author":"Jonas","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2019.04.002_bib23","first-page":"685A","article-title":"Entecavir pharmacokinetics among nucleos\/tide-na\u0131ve pediatric subjects","volume":"58","author":"Chang","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2019.04.002_bib24","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s12664-013-0323-4","article-title":"Occult hepatitis B virus infection as a cause of post transfusion hepatitis in patients with cancers","volume":"32","author":"Sodhi","year":"2013","journal-title":"Indian J Gastroenterol"},{"key":"10.1016\/j.jceh.2019.04.002_bib25","doi-asserted-by":"crossref","first-page":"573","DOI":"10.4103\/0256-4947.87091","article-title":"Assessment of hepatitis B immunization status after antineoplastic therapy in children with cancer","volume":"31","author":"Karaman","year":"2011","journal-title":"Ann Saudi Med"},{"key":"10.1016\/j.jceh.2019.04.002_bib26","first-page":"555","article-title":"Escalated regimen of hepatitis B vaccine in childhood hematological malignancies while on chemotherapy","volume":"41","author":"Ghosh","year":"2010","journal-title":"South east Asian J Trop Med Public Health"},{"key":"10.1016\/j.jceh.2019.04.002_bib27","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1007\/s12664-015-0595-y","article-title":"The efficacy of accelerated, multiple, double-dose hepatitis B vaccine against hepatitis B virus infection in cancer patients receiving chemotherapy","volume":"34","author":"Sodhi","year":"2015","journal-title":"Indian J Gastroenterol"},{"key":"10.1016\/j.jceh.2019.04.002_bib28","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/j.1365-2036.2009.04158.x","article-title":"Screening for hepatitis B in chemotherapy patients: survey of current oncology practices","volume":"31","author":"Tran","year":"2010","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jceh.2019.04.002_bib29","doi-asserted-by":"crossref","first-page":"e32","DOI":"10.1200\/JOP.2011.000450","article-title":"Low rates of hepatitis B virus screening at the onset of chemotherapy","volume":"8","author":"Hwang","year":"2012","journal-title":"J\u00a0Oncol Pract"},{"key":"10.1016\/j.jceh.2019.04.002_bib30","doi-asserted-by":"crossref","first-page":"3270","DOI":"10.1200\/JCO.2011.35.1635","article-title":"Cost-effectiveness of universal hepatitis B virus screening in patients beginning chemotherapy for solid tumors","volume":"29","author":"Day","year":"2011","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jceh.2019.04.002_bib31","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1002\/hep.29800","article-title":"Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance","volume":"67","author":"Terrault","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2019.04.002_bib32","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.jhep.2017.03.021","article-title":"EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection","volume":"67","year":"2017","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2019.04.002_bib33","first-page":"403","article-title":"INASL guidelines on the management of hepatitis B virus infection in patients receiving chemotherapy, biologicals, immunosuppressants and corticosteroids","volume":"8","author":"Arora","year":"2018","journal-title":"JCEH"},{"key":"10.1016\/j.jceh.2019.04.002_bib34","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1053\/j.gastro.2012.05.037","article-title":"Efficacy of entecavir with or without tenofovir disoproxil fumarate for nucleos(t)ide-naive patients with chronic hepatitis B","volume":"143","author":"Lok","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jceh.2019.04.002_bib35","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jhep.2008.12.019","article-title":"Baseline characteristics and early on-treatment response predict the outcomes of 2 years of telbivudine treatment of chronic hepatitis B","volume":"51","author":"Zeuzem","year":"2009","journal-title":"J\u00a0Hepatol"}],"container-title":["Journal of Clinical and Experimental Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0973688319300763?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0973688319300763?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T06:05:50Z","timestamp":1760853950000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0973688319300763"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["S0973688319300763"],"URL":"https:\/\/doi.org\/10.1016\/j.jceh.2019.04.002","relation":{},"ISSN":["0973-6883"],"issn-type":[{"type":"print","value":"0973-6883"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Entecavir is Safe and Effective in Long Term for the Treatment of Hepatitis B in Immunocompromised Children","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical and Experimental Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jceh.2019.04.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Indian National Association for Study of the Liver. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}